Dose escalation of the anti-tissue factor pathway inhibitor marstacimab in participants with severe haemophilia without inhibitors: Results from the phase 3 basis and long-term extension trials - Jimenez-Yuste, Victor; Palladino, Andrew; McDonald, Regina; McComb, Bryan; Hwang, Eunhee; Taylor, Carrie Turich; Teeter, John (HAEMOPHILIA, 2024)